Evolent Health Stock Price, News & Analysis (NYSE:EVH) $28.55 +0.75 (+2.70%) (As of 12:02 PM ET) Add Compare Share Share Today's Range$27.51▼$28.6450-Day Range$23.63▼$29.7452-Week Range$23.33▼$36.70Volume161,778 shsAverage Volume1.03 million shsMarket Capitalization$3.28 billionP/E RatioN/ADividend YieldN/APrice Target$45.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Evolent Health MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.86 Rating ScoreUpside/Downside63.7% Upside$45.50 Price TargetShort InterestBearish7.19% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.67Based on 2 Articles This WeekInsider TradingSelling Shares$330,000 Sold Last QuarterProj. Earnings Growth102.70%From $0.37 to $0.75 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.91 out of 5 starsComputer And Technology Sector390th out of 603 stocksManagement Services Industry5th out of 5 stocks 3.4 Analyst's Opinion Consensus RatingEvolent Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on 6 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $45.50, Evolent Health has a forecasted upside of 63.7% from its current price of $27.79.Amount of Analyst CoverageEvolent Health has only been the subject of 4 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted7.19% of the outstanding shares of Evolent Health have been sold short.Short Interest Ratio / Days to CoverEvolent Health has a short interest ratio ("days to cover") of 8.5.Change versus previous monthShort interest in Evolent Health has recently increased by 0.49%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldEvolent Health does not currently pay a dividend.Dividend GrowthEvolent Health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for EVH. Previous Next 1.3 News and Social Media Coverage News SentimentEvolent Health has a news sentiment score of -0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Evolent Health this week, compared to 2 articles on an average week.MarketBeat Follows4 people have added Evolent Health to their MarketBeat watchlist in the last 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Evolent Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $330,000.00 in company stock.Percentage Held by InsidersOnly 3.30% of the stock of Evolent Health is held by insiders. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Evolent Health are expected to grow by 102.70% in the coming year, from $0.37 to $0.75 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Evolent Health is -27.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Evolent Health is -27.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEvolent Health has a P/B Ratio of 2.92. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Evolent Health Stock (NYSE:EVH)Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, offers clinical and administrative solutions to payers and providers in the United States. The company operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology, cardiology, and musculoskeletal markets; physician-oriented total cost of care solutions; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.Read More EVH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EVH Stock News HeadlinesNovember 30, 2023 | americanbankingnews.comRoyal Bank of Canada Lowers Evolent Health (NYSE:EVH) Price Target to $42.00November 22, 2023 | msn.comPiper Sandler bullish on Evolent Health, Omnicell, Health CatalystDecember 1, 2023 | Edge On The Street (Ad)Is Gold Really Boring?Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks. November 22, 2023 | americanbankingnews.comEvolent Health, Inc. (NYSE:EVH) Receives Average Rating of "Moderate Buy" from BrokeragesNovember 21, 2023 | americanbankingnews.comEvolent Health, Inc. (NYSE:EVH) President Daniel Joseph Mccarthy Sells 11,000 Shares of StockNovember 20, 2023 | finance.yahoo.comWall Street Analysts See a 56.84% Upside in Evolent Health (EVH): Can the Stock Really Move This High?November 6, 2023 | markets.businessinsider.comEvolent Health’s Strong Financial Performance and Positive Market Response Reinforces Buy RatingNovember 5, 2023 | finance.yahoo.comEvolent Health, Inc. (NYSE:EVH) Q3 2023 Earnings Call TranscriptDecember 1, 2023 | DTI Trader (Ad)New CBOE “special perk” helps traders target income every weekendYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. November 3, 2023 | markets.businessinsider.comCharles Rhyee Recommends ‘Buy’ for Evolent Health’s Stock: Strong Q3 Results and Promising Future PartnershipsNovember 3, 2023 | finanznachrichten.deEvolent Health: Evolent Announces Third Quarter 2023 ResultsNovember 3, 2023 | finance.yahoo.comEvolent Health (EVH) Q3 2023 Earnings Call TranscriptNovember 3, 2023 | finance.yahoo.comEvolent Health Inc (EVH) Reports Q3 2023 Earnings: Revenue Up by 44.9% YoY, Net Loss of $33.November 3, 2023 | finance.yahoo.comEvolent Health (EVH) Surpasses Q3 Earnings and Revenue EstimatesNovember 3, 2023 | finance.yahoo.comEvolent Health Inc (EVH) Reports Q3 2023 Earnings: Revenue Up by 44.9% YoY, Net Loss of $33. ...November 2, 2023 | finance.yahoo.comEvolent Announces Third Quarter 2023 ResultsOctober 24, 2023 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Shockwave Medical (SWAV), Eledon Pharmaceuticals (ELDN)October 23, 2023 | finance.yahoo.comWall Street Analysts Think Evolent Health (EVH) Could Surge 76.14%: Read This Before Placing a BetOctober 16, 2023 | msn.comUBS Initiates Coverage of Evolent Health Inc - (EVH) with Buy RecommendationOctober 16, 2023 | finance.yahoo.comEvolent Health (NYSE:EVH) rallies 3.8% this week, taking three-year gains to 147%October 10, 2023 | finance.yahoo.comEvolent to release third quarter financial results on Thursday, Nov. 2, 2023, and participate in upcoming investor conferencesOctober 6, 2023 | finance.yahoo.comWall Street Analysts Believe Evolent Health (EVH) Could Rally 77.45%: Here's is How to TradeOctober 5, 2023 | finance.yahoo.comEvolent Health (EVH) Moves to Buy: Rationale Behind the UpgradeOctober 4, 2023 | seekingalpha.comA First Evaluation On Evolent HealthOctober 1, 2023 | markets.businessinsider.comTruist Financial Keeps Their Hold Rating on Evolent Health (EVH)September 25, 2023 | finance.yahoo.comEvolent Health, Inc. (NYSE:EVH): Are Analysts Optimistic?September 22, 2023 | msn.com30 US States Pause Medicaid Disenrollment Due To Technical GlitchSee More Headlines Receive EVH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/02/2023Today12/01/2023Fiscal Year End12/31/2023Next Earnings (Estimated)2/28/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Management services Sub-IndustryN/A SectorComputer and Technology Current SymbolNYSE:EVH CUSIPN/A CIK1628908 Webwww.evolenthealth.com Phone(571) 389-6000Fax571-389-6001Employees5,100Year FoundedN/APrice Target and Rating Average Stock Price Target$45.50 High Stock Price Target$59.00 Low Stock Price Target$34.00 Potential Upside/Downside+63.7%Consensus RatingModerate Buy Rating Score (0-4)2.86 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($1.02) Trailing P/E RatioN/A Forward P/E Ratio75.11 P/E GrowthN/ANet Income$-19,160,000.00 Net Margins-5.08% Pretax Margin-9.19% Return on Equity4.83% Return on Assets2.07% Debt Debt-to-Equity Ratio0.55 Current Ratio1.04 Quick Ratio1.04 Sales & Book Value Annual Sales$1.35 billion Price / Sales2.36 Cash Flow$1.42 per share Price / Cash Flow19.59 Book Value$9.53 per share Price / Book2.92Miscellaneous Outstanding Shares114,960,000Free Float111,166,000Market Cap$3.19 billion OptionableOptionable Beta1.44 The Best High-Yield Dividend Stocks for 2023Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Seth Barrie Blackley (Age 44)Co-Founder, CEO & Director Comp: $1.79MMr. Dan McCarthy (Age 38)CEO of New Century Health & President Comp: $1.29MMr. John Paul Johnson (Age 39)Chief Financial Officer Comp: $994.22kMr. Jonathan David Weinberg J.D. (Age 55)Chief Legal Officer, General Counsel & Secretary Comp: $696.07kMs. Emily Rafferty (Age 40)Chief Operating Officer Mr. Aammaad Shams (Age 39)Chief Accounting Officer Comp: $341.78kMs. Jessica SomersSenior Vice President of Corporate DevelopmentMs. Kali BeyahChief People & Brand OfficerDr. John Tam M.D.Chief Strategy OfficerDr. Andrew Hertler M.D.Chief Medical Officer of New Century HealthMore ExecutivesKey CompetitorsAutohomeNYSE:ATHMnCinoNASDAQ:NCNOSigma LithiumNASDAQ:SGMLPagSeguro DigitalNYSE:PAGSRapid7NASDAQ:RPDView All CompetitorsInsiders & InstitutionsAmerican Century Companies Inc.Sold 52,155 shares on 11/30/2023Ownership: 1.251%IMA Wealth Inc.Sold 23,452 shares on 11/28/2023Ownership: 0.038%Deutsche Bank AGBought 7,188 shares on 11/24/2023Ownership: 0.085%Polar Capital Holdings PlcSold 22,763 shares on 11/22/2023Ownership: 0.021%Comerica BankBought 38,912 shares on 11/21/2023Ownership: 0.057%View All Insider TransactionsView All Institutional Transactions EVH Stock Analysis - Frequently Asked Questions Should I buy or sell Evolent Health stock right now? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last year. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" EVH shares. View EVH analyst ratings or view top-rated stocks. What is Evolent Health's stock price target for 2024? 7 equities research analysts have issued 1 year price objectives for Evolent Health's stock. Their EVH share price targets range from $34.00 to $59.00. On average, they predict the company's share price to reach $45.50 in the next twelve months. This suggests a possible upside of 63.7% from the stock's current price. View analysts price targets for EVH or view top-rated stocks among Wall Street analysts. How have EVH shares performed in 2023? Evolent Health's stock was trading at $28.08 on January 1st, 2023. Since then, EVH shares have decreased by 1.0% and is now trading at $27.79. View the best growth stocks for 2023 here. When is Evolent Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 28th 2024. View our EVH earnings forecast. How were Evolent Health's earnings last quarter? Evolent Health, Inc. (NYSE:EVH) released its quarterly earnings data on Thursday, November, 2nd. The technology company reported $0.19 earnings per share for the quarter. The technology company earned $511.02 million during the quarter, compared to the consensus estimate of $508.21 million. Evolent Health had a negative net margin of 5.08% and a positive trailing twelve-month return on equity of 4.83%. What ETFs hold Evolent Health's stock? ETFs with the largest weight of Evolent Health (NYSE:EVH) stock in their portfolio include Fidelity Digital Health ETF (FDHT), Harbor Corporate Culture Small Cap ETF (HAPS), Fidelity Disruptive Medicine ETF (FMED), Harbor Small Cap Explorer ETF (QWST).LeaderShares Activist Leaders ETF (ACTV) and What is Seth Blackley's approval rating as Evolent Health's CEO? 12 employees have rated Evolent Health Chief Executive Officer Seth Blackley on Glassdoor.com. Seth Blackley has an approval rating of 100% among the company's employees. This puts Seth Blackley in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Evolent Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Evolent Health investors own include CA (CA), BlackRock (BLK), Universal Insurance (UVE), Endologix (ELGX), Advanced Micro Devices (AMD), Energy Transfer (ET), Chipotle Mexican Grill (CMG), Ford Motor (F), Cisco Systems (CSCO) and Heron Therapeutics (HRTX). When did Evolent Health IPO? (EVH) raised $150 million in an initial public offering (IPO) on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers. Who are Evolent Health's major shareholders? Evolent Health's stock is owned by many different retail and institutional investors. Top institutional investors include FMR LLC (14.35%), Rock Springs Capital Management LP (3.36%), RA Capital Management L.P. (2.38%), Eventide Asset Management LLC (2.30%), William Blair Investment Management LLC (2.32%) and Loomis Sayles & Co. L P (1.81%). Insiders that own company stock include Cheryl Scott, Daniel Joseph Mccarthy, Diane Holder, Frank J Williams, Frank J Williams, John Paul Johnson, Jonathan Weinberg, Mary Bridget Duffy, Seth Blackley, Simon Maisey and Steve Tutewohl. View institutional ownership trends. How do I buy shares of Evolent Health? Shares of EVH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NYSE:EVH) was last updated on 12/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evolent Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.